European Medicines Agency meeting early to discuss Moderna coronavirus vaccine

1 minute read

An employee shows the Moderna coronavirus disease (COVID-19) vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in New York, U.S., December 21, 2020. REUTERS/Eduardo Munoz

Register now for FREE unlimited access to Reuters.com

AMSTERDAM, Jan 4 (Reuters) - The European Medicines Agency was holding early meetings on Monday to discuss the Moderna vaccine against COVID-19, a spokesperson said.

EMA’s human medicines committee (CHMP) could issue an opinion on approving the vaccine later on Monday. Meetings had been scheduled for Wednesday.

Register now for FREE unlimited access to Reuters.com
Reporting by Anthony Deutsch; Editing by Jan Harvey

Our Standards: The Thomson Reuters Trust Principles.